Crossmark

CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics

Crossref DOI link: https://doi.org/10.1186/s12935-019-0726-0

Published Online: 2019-01-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghosh, Debarati

Venkataramani, Prabhadevi

Nandi, Saikat

Bhattacharjee, Sonali http://orcid.org/0000-0003-0522-3361
License Information

Text and Data Mining valid from 2019-01-08
More Information

Article History

Received: 13 November 2018

Accepted: 2 January 2019

First Online: 8 January 2019